Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2016

01-08-2016 | Rapid Communications

Gastric Enterovirus Infection: A Possible Causative Etiology of Gastroparesis

Authors: Jodie A. Barkin, Frank Czul, Jamie S. Barkin, Nancy G. Klimas, Irma R. Rey, Baharak Moshiree

Published in: Digestive Diseases and Sciences | Issue 8/2016

Login to get access

Abstract

Background

Gastroparesis (GP) is a disabling chronic gastroenterologic disorder with high morbidity that severely impacts patients’ quality of life. GP can present acutely after a viral-like gastrointestinal illness resulting in speculation that in some patients, neurologic damage caused by the infection might underlie the pathogenesis of idiopathic gastroparesis (IGP).

Aims

The aim of this study is to document case reports of Enterovirus (EV) infection as a possible cause of IGP.

Methods

Eleven patients referred with a diagnosis of GP underwent workup to exclude known causes of GP. Those with a history of flu-like symptoms or gastroenteritis prior to onset of GP symptoms had gastric biopsies taken during upper endoscopy to assess for the presence of gastric mucosal EV infection. Data on presenting symptoms, extra-intestinal symptoms and conditions, prior nutritional support requirements, upper endoscopy findings, and response to therapy were cataloged.

Results

Eleven patients were diagnosed as IGP. Nine had active EV infection on gastric biopsies and were included (7/9 female, mean age 43 years). Eight out of nine received EV treatment with antivirals and/or immune therapies, with a wide degree of variability in treatment regimens. Four out of eight who received EV treatment had symptomatic improvement. One patient had stable symptoms. Three patients are currently undergoing therapy.

Conclusions

Gastric EV infection was frequently detected (82 %) in patients undergoing investigation for IGP. Antiviral and/or immune therapies against EV seem to be favorable, as most of our patients had resolution of their GP symptoms after treatment. This is the first study to identify EV as a possible infectious etiology of IGP.
Literature
1.
go back to reference Jung HK, Choung RS, Locke GR III, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–1233.CrossRefPubMed Jung HK, Choung RS, Locke GR III, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009;136:1225–1233.CrossRefPubMed
2.
go back to reference Hyett B, Martinez FJ, Gill BM, et al. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology. 2009;137:445–452.CrossRefPubMed Hyett B, Martinez FJ, Gill BM, et al. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology. 2009;137:445–452.CrossRefPubMed
3.
go back to reference Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001;96:71–76.CrossRefPubMed Talley NJ, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001;96:71–76.CrossRefPubMed
4.
5.
go back to reference Stein B, Everhart KK, Lacy BE. Gastroparesis: a review of current diagnosis and treatment options. J Clin Gastroenterol. 2015;49:550–558.CrossRefPubMed Stein B, Everhart KK, Lacy BE. Gastroparesis: a review of current diagnosis and treatment options. J Clin Gastroenterol. 2015;49:550–558.CrossRefPubMed
6.
go back to reference Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–2404.CrossRefPubMed Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–2404.CrossRefPubMed
7.
go back to reference Hasler WL, Wilson LA, Parkman HP, et al. Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol. 2011;106:1492–1502.CrossRefPubMed Hasler WL, Wilson LA, Parkman HP, et al. Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol. 2011;106:1492–1502.CrossRefPubMed
8.
go back to reference Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140:101–115.CrossRefPubMed Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140:101–115.CrossRefPubMed
9.
go back to reference Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18–37.CrossRefPubMed Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18–37.CrossRefPubMed
10.
go back to reference Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis—clinical characteristics and long-term outcomes. Am J Gastroenterol. 1997;92:1501–1506.PubMed Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis—clinical characteristics and long-term outcomes. Am J Gastroenterol. 1997;92:1501–1506.PubMed
11.
go back to reference Spiller RC. Infection, immune function, and functional gut disorders. Clin Gastroenterol Hepatol. 2004;2:445–455.CrossRefPubMed Spiller RC. Infection, immune function, and functional gut disorders. Clin Gastroenterol Hepatol. 2004;2:445–455.CrossRefPubMed
12.
go back to reference Vassallo M, Camilleri M, Caron BL, et al. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology. 1991;100:252–258.CrossRefPubMed Vassallo M, Camilleri M, Caron BL, et al. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology. 1991;100:252–258.CrossRefPubMed
13.
go back to reference Debinski HS, Kamm MA, Talbot IC, et al. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut. 1997;41:100–106.CrossRefPubMedPubMedCentral Debinski HS, Kamm MA, Talbot IC, et al. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut. 1997;41:100–106.CrossRefPubMedPubMedCentral
14.
go back to reference Lobrano A, Blanchard K, Abell TL, et al. Postinfectious gastroparesis related to autonomic failure: a case report. Neurogastroenterol Motil. 2006;18:162–167.CrossRefPubMed Lobrano A, Blanchard K, Abell TL, et al. Postinfectious gastroparesis related to autonomic failure: a case report. Neurogastroenterol Motil. 2006;18:162–167.CrossRefPubMed
15.
go back to reference Camilleri M, Fealey RD. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease. A causal association? Dig Dis Sci. 1990;35:609–616.CrossRefPubMed Camilleri M, Fealey RD. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease. A causal association? Dig Dis Sci. 1990;35:609–616.CrossRefPubMed
16.
go back to reference Parkman HP, McCallum RW. Gastroparesis Pathophysiology, Presentation and Treatment. New York, NY: Humana Press; 2012. Parkman HP, McCallum RW. Gastroparesis Pathophysiology, Presentation and Treatment. New York, NY: Humana Press; 2012.
17.
go back to reference Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456–1462.CrossRefPubMed Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456–1462.CrossRefPubMed
18.
go back to reference Chia JK, Chia AY. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol. 2008;61:43–48.CrossRefPubMed Chia JK, Chia AY. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol. 2008;61:43–48.CrossRefPubMed
19.
go back to reference Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003;18:141–150.CrossRefPubMed Revicki DA, Rentz AM, Dubois D, et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003;18:141–150.CrossRefPubMed
20.
go back to reference El-Serag HB, Chia J, Chia AY. Enterovirus infection of the stomach is associated with dyspepsia: a pilot controlled study. Gastroenterology. 2007;132:A73. El-Serag HB, Chia J, Chia AY. Enterovirus infection of the stomach is associated with dyspepsia: a pilot controlled study. Gastroenterology. 2007;132:A73.
21.
go back to reference Chia JK, Chia AY, Wang D, et al. Functional dyspepsia and chronic gastritis associated with enteroviruses. Open J Gastroenterol. 2015;5:21–27.CrossRef Chia JK, Chia AY, Wang D, et al. Functional dyspepsia and chronic gastritis associated with enteroviruses. Open J Gastroenterol. 2015;5:21–27.CrossRef
22.
go back to reference Khetsuriani N, LaMonte-Fowlkes A, Oberste S, et al. Enterovirus surveillance—United States, 1970–2005. MMWR Surveill Summ.. 2006;55:1–20.PubMed Khetsuriani N, LaMonte-Fowlkes A, Oberste S, et al. Enterovirus surveillance—United States, 1970–2005. MMWR Surveill Summ.. 2006;55:1–20.PubMed
23.
go back to reference Flanagan EP, Saito YA, Lennon VA, et al. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil. 2014;26:1285–1297.CrossRefPubMedPubMedCentral Flanagan EP, Saito YA, Lennon VA, et al. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil. 2014;26:1285–1297.CrossRefPubMedPubMedCentral
25.
go back to reference Wang SM, Lei HY, Huang MC, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with Enterovirus 71-associated brainstem encephalitis. J Clin Virol. 2006;37:47–52.CrossRefPubMed Wang SM, Lei HY, Huang MC, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with Enterovirus 71-associated brainstem encephalitis. J Clin Virol. 2006;37:47–52.CrossRefPubMed
Metadata
Title
Gastric Enterovirus Infection: A Possible Causative Etiology of Gastroparesis
Authors
Jodie A. Barkin
Frank Czul
Jamie S. Barkin
Nancy G. Klimas
Irma R. Rey
Baharak Moshiree
Publication date
01-08-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4227-x

Other articles of this Issue 8/2016

Digestive Diseases and Sciences 8/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.